title: Other new drugs in head and neck cancer.
abstract: Chemotherapy plays a definite role in the management of head and neck cancer. Several new agents have been introduced recently. The following are reviewed briefly: gemcitabine, edatexate, MTA, vinorelbine and topoisomerase I inhibitors.
authors.affiliation: Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek), The Netherlands.
authors.forename: M J
authors.initials: MJ
authors.lastname: de Jonge
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors